Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization
Avtorji:ID Rodriguez Alvarez, Adriana A. (Avtor)
ID Cieri, Isabella F. (Avtor)
ID Naidu Boya, Mounika (Avtor)
ID Patel, Shiv (Avtor)
ID Agrawal, Aniket (Avtor)
ID Suarez Ferreira, Sasha P. (Avtor)
ID Alli, Christianah (Avtor)
ID Sharma, Shruti (Avtor)
ID Dua, Anahita (Avtor)
ID Žigon, Polona (Gostujoči urednik)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (355,21 KB)
MD5: 3D1163E74F748FD25F1914AFF2352DD9
 
URL URL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1615816/full
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Introduction: Inflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple diseases and can thus, also impact recovery post-treatment and surgical outcomes. Yet, there is a paucity of data regarding the relationship between inflammatory biomarkers and arterial thrombotic potential in peripheral artery disease (PAD) patients post-revascularization. Our pilot study attempts to fill this gap by evaluating if the expression of inflammatory biomarkers in PAD patients correlates with the incidence of thrombotic events post-revascularization. Methods: Plasma samples were prospectively collected from PAD patients who underwent revascularization from 2021 to 2023 at monthly time points for 6 months from the procedure. Patients were followed for a total of 6 months post-procedure and those who experienced thrombotic events were identified. Nine patients with thrombotic events and 16 with non-thrombotic events along with 5 healthy volunteers were analyzed. Plasma samples were analyzed for the following pro-inflammatory markers: IL-1β (Interleukin-1 beta), IL-6, and TNF-α (Tumor Necrosis Factor - alpha), GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), IFNγ (Interferon-gamma), IL-8, MCP-1 (Monocyte Chemoattractant Protein-1). The Kruskal-Wallis test was performed to compare bio-inflammatory marker levels between groups. Results: A total of 303 patients were enrolled, of which 59 had thrombotic events. There were no differences between medications or disease burden between groups. Levels of circulating IL-6 and TNF- α were significantly higher in the thrombosis cohort compared to the non-thrombosis cohort (55 vs. 38, p < 0.02) and (159 vs. 110, p < 0.02) respectively. Although there was a trend toward significance for IL-1β between the thrombotic cohort and non-thrombotic cohort, it did not reach statistical significance (18 vs. 11.5, p = NS). There was no difference observed in aspirin's ability to dampen the inflammatory response between the two groups as all patients were on aspirin between the groups evaluated. Conclusion: Pro-inflammatory markers IL-6 and TNF-α are significantly increased in patients, 1 month prior to an arterial thrombotic event, as compared to patients without thrombotic events. These biomarkers could predict impending thrombosis in patients with PAD post-revascularization.
Ključne besede:inflammation, interleukin-6, peripheral artery disease (PAD), thrombosis, tumor necrosis factor-alpha
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:Str. 1-7
Številčenje:Vol. 12, no. [article no.] 1615816
PID:20.500.12556/DiRROS-24667 Novo okno
UDK:616.1/.4
ISSN pri članku:2296-858X
DOI:10.3389/fmed.2025.1615816 Novo okno
COBISS.SI-ID:254748163 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 25. 10. 2025;
Datum objave v DiRROS:11.12.2025
Število ogledov:39
Število prenosov:21
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in medicine
Skrajšan naslov:Front. med.
Založnik:Frontiers Media S.A.
ISSN:2296-858X
COBISS.SI-ID:523095065 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Program financ.:National Institute for Health Research
Številka projekta:R21AG077310
Naslov:National Institute of Health

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:vnetje, interlevkin 6, periferna arterijska bolezen, tromboza, faktor tumorske nekroze alfa


Nazaj